Kaynak: MarketBeat
Haber Ajansı
Hisse Senedi
Orta Önem
Nuvation Bio Q2 Earnings Call Highlights
Nuvation Bio NYSE: NUVB reported second-quarter total revenue of $31.7 million, including $23.2 million in net U.S. product revenue from IBTROZI, as the company said use of the ROS1-targeted lung cancer therapy continued to shift toward first-line patients.
İlgili Semboller
1
N
NUVB
NUVB
Kaynak: MarketBeat
Kaynağı Ziyaret Et